Telomir Pharmaceuticals (TELO) News Today $1.16 +0.03 (+2.21%) As of 03:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Telomir Pharmaceuticals Inc News (TELO) - Investing.comJuly 1, 2025 | investing.comTelomir Pharmaceuticals Reports Positive Preclinical DataJune 18, 2025 | tipranks.comTELO Rises on Promising Telomir-1 Preclinical ResultsJune 13, 2025 | insidermonkey.comTELO Rises on Promising Telomir-1 Preclinical ResultsJune 13, 2025 | msn.comTELO Continues Trend of Significant Trial AnnouncementsJune 11, 2025 | msn.comTelomir Pharmaceuticals Announces Telomir-1 Resets the Body’s Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated ...June 7, 2025 | usatoday.comTELO Data Indicates Aging Reversal PotentialJune 6, 2025 | finance.yahoo.comTelomir Pharmaceuticals Joins BIO Convention for PartnershipsJune 2, 2025 | tipranks.comTelomir Pharmaceuticals, Inc: Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration Animal Model Using FDA ...May 29, 2025 | finanznachrichten.deTELO Produces Results with Exciting AMD ImplicationsMay 29, 2025 | msn.comTelomir Pharmaceuticals CFO Michelle Yanez Leaves Company; Resignation Was a Mutual SeparationMay 21, 2025 | marketwatch.comTelomir Pharmaceuticals Appoints New Chief Financial OfficerMay 21, 2025 | tipranks.comTelomir unveils new drug candidate against resistant bacteriaMay 16, 2025 | investing.comTELO Announces Exciting DiscoveryMay 15, 2025 | msn.comTELO Announces Promising Aging Reversal Test ResultsMay 8, 2025 | msn.comTelomir Pharmaceuticals Unveils Promising Preclinical Data on Telomir-1May 7, 2025 | tipranks.comTelomir Pharmaceuticals (TELO) Projected to Post Earnings on MondayMay 7, 2025 | marketbeat.comGeode Capital Management LLC Has $1.71 Million Stock Holdings in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)May 2, 2025 | marketbeat.comTelomir Pharmaceuticals, Inc. (TELO)March 21, 2025 | finance.yahoo.comTELO Study Shows Cancer-Related BreakthroughMarch 19, 2025 | msn.comTelomir Pharmaceuticals announces anti-cancer effects in prostate cancer animal modelMarch 19, 2025 | msn.comTelomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study ShowsMarch 19, 2025 | benzinga.comTelomir Pharmaceuticals, Inc. (NASDAQ:TELO) Short Interest Up 34.4% in FebruaryMarch 4, 2025 | marketbeat.comRodman & Renshaw Begins Coverage on Telomir Pharmaceuticals (NASDAQ:TELO)February 22, 2025 | marketbeat.comZacks Small Cap Issues Negative Forecast for TELO EarningsFebruary 7, 2025 | marketbeat.comTelomir Pharmaceuticals (NASDAQ:TELO) Releases Earnings Results, Misses Estimates By $0.05 EPSFebruary 4, 2025 | marketbeat.comTelomir Pharmaceuticals, Inc. (NASDAQ:TELO) Short Interest Up 58.9% in DecemberJanuary 16, 2025 | marketbeat.comGeode Capital Management LLC Grows Stock Holdings in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)January 9, 2025 | marketbeat.comShort Interest in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Expands By 22.9%December 29, 2024 | marketbeat.comWhy Is Telomir Pharmaceuticals Stock Trading Higher On Tuesday?December 3, 2024 | benzinga.comWhat is Zacks Small Cap's Forecast for TELO FY2024 Earnings?November 25, 2024 | marketbeat.comTelomir Pharmaceuticals (NASDAQ:TELO) Trading Up 3.8% - Still a Buy?November 12, 2024 | marketbeat.comTelomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Large Growth in Short InterestOctober 10, 2024 | marketbeat.comTelomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Large Increase in Short InterestSeptember 14, 2024 | marketbeat.comTelomir Pharmaceuticals (NASDAQ:TELO) Trading Up 2.2%September 14, 2024 | marketbeat.comTelomir Pharmaceuticals Inc (TELO)September 1, 2024 | investing.comTelomir Pharmaceuticals (NASDAQ:TELO) Trading Up 3.2%August 22, 2024 | marketbeat.comTELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q2 2024August 13, 2024 | investorplace.comTelomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher ChapmanAugust 12, 2024 | globenewswire.comTelomir Pharmaceuticals, Inc.'s Lock-Up Period Will Expire on August 7th (NASDAQ:TELO)July 31, 2024 | marketbeat.comTelomir Pharmaceuticals (NASDAQ:TELO) Trading Up 15.5%July 6, 2024 | marketbeat.comTelomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap IndexesJuly 2, 2024 | markets.businessinsider.comTelomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting PanelJune 17, 2024 | globenewswire.comTelomir Pharmaceuticals (NASDAQ:TELO) Trading 2.2% Higher June 14, 2024 | marketbeat.comTelomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1May 30, 2024 | globenewswire.comTELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q1 2024May 13, 2024 | investorplace.comTelomir Pharmaceuticals (Nasdaq:TELO) HeadlineTrading was temporarily halted for "TELO" at 11:04 AM with a stated reason of "LULD pause."...April 22, 2024 | marketbeat.comTelomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.April 16, 2024 | globenewswire.comTelomir Pharmaceuticals' Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024April 2, 2024 | globenewswire.comUPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesMarch 29, 2024 | globenewswire.com Get Telomir Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter. Email Address TELO Media Mentions By Week TELO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TELO News Sentiment▼1.890.97▲Average Medical News Sentiment TELO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TELO Articles This Week▼10▲TELO Articles Average Week Get Telomir Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Citius Oncology News Nkarta News Inhibikase Therapeutics News Fate Therapeutics News Seres Therapeutics News Genelux News FitLife Brands News Protara Therapeutics News Korro Bio News Skye Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TELO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
